I have seen large pharma pay crazy prices for companies that made no sense. My brother worked for a European pharmaceutical that got acquired for $30b with sales of $2.3b. Very little value in the pipeline but it appeared to augment a lagging pharma group that the analysts were concerned about. Lol!